COVID-19 Research
Identifying potential drug targets in the structural proteins of SARS-Cov-2
Working on mRNA/peptide-based vaccine for SARS-Cov-2
Engineering of epitope peptides from structural and non-structural proteins of coronavirus 2019-nCoV on Virus-Like particle (VLPs) to develop vaccine candidates
Rational Design of Broad-Spectrum Antiviral Peptides Targeting SARS-CoV2-Spike Protein
Neutralizing Peptide Antibody Designed for Human Complement Fragment 5a (hC5a)
Identification and development of potential antiviral drug molecules against SARS-CoV-2
Development of some mammalian cell based models to screen potent leads that might inhibit viral infection
Machine learning based approach to optimize novel small molecules towards development of novel therapeutics against COVID19
Optimize ultraviolet irradiation of an infected patient's blood to improve the immunity
Re-purposing of FDA drugs and exploitation of ancient Ayurvedic knowledge to discover novel inhibitors to block coronavirus propagation
Pages
